US4305935A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Bone formation stimulant
Assignee: Teijin Ltd
•
Filing: 1980-04-09
•
Granted: 1981-12-15
•
Expires: 2000-04-09
Abstract
Abstract This is a bone formation stimulant containing vitamin D 3 or its derivative and acetylsalicylic acid or its formaceutically permissible salt. The present bone formation stimulant is used to cure or prevent the diseases caused by the deficiency of vitamin D or related diseases by dosing human beings or animals with it.
Inventors
- 👤 Hiroyuki Kawashima
- 👤 Minoru Hayashi
- 👤 Seiji Kurozumi
- 👤 Yoshiki Suzuki
- 👤 Yoshinobu Hashimoto
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 11:29
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/60; A61P; A61P3/00; A61P3/02; A61P3/12; A61P3/14
Claims Analysis
Total Claims: 5
Claim 1
Independent Claim
40 words
A composition for preventing bone salt dissoltuion caused by vitamin D 3 or its active derivatives which contains effective amounts of (1) vitamin D 3 or an active derivative thereof and (2) acetylsalicylic acid or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim
40 words
A composition for preventing bone salt dissoltuion caused by vitamin D 3 or its active derivatives which contains effective amounts of (1) vitamin D 3 or an active derivative thereof and (2) acetylsalicylic acid or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
32 words
A composition according to claim 1, wherein the derivative of vitamin D 3 is one or more vitamin D 3 derivatives selected from the group consisting of 1α-hydroxycholecalciferol, 1α,24(R)-dihydroxycholecalciferol, 1α,25-dihydroxycholecalciferol, and 24,25-dihydroxycholecalciferol.
Claim 4
Dependent Claim
34 words
A composition according to claim 1, containing 0.01 to 100×10 -6 part by weight of vitamin D 3 or said derivative per 1 part by weight of acetylsalicylic acid or said pharmaceutically acceptable salt.
Claim 5
Dependent Claim
25 words
A composition according to claim 1, wherein vitamin D 3 or said derivative thereof is stabilized by a β-cyclic dextrin to form an inclusion compound.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-12-14 | 1985-06-15 | 1985-12-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-12-14 | 1989-06-15 | 1989-12-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-12-14 | 1993-06-15 | 1993-12-15 | $7700.00 | Window Closed / Lapsed |